Long-Term Treatment With a Dipeptidyl Peptidase-4 Inhibitor, Sitagliptin, Suppresses Intestinal Tumors in Models of Diabetes and Obesity

被引：0
|
作者：
Fujiwara, Kaori
Yorifuji, Naoki
Nouda, Sadaharu
Kakimoto, Kazuki
Okada, Toshihiko
Kawakami, Ken
Takeuchi, Toshihisa
Inoue, Takuya
Higuchi, Kazuhide
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)32025-X
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1926
引用
收藏
页码：S591 / S591
页数：1
相关论文
共 50 条
  • [41] Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes
    Ogawa, Susumu
    Ishiki, Mikihito
    Nako, Kazuhiro
    Okamura, Masashi
    Senda, Miho
    Mori, Takefumi
    Ito, Sadayoshi
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2011, 223 (02): : 133 - 135
  • [42] Saxagliptin A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
    Lam, Sum
    Saad, Maha
    CARDIOLOGY IN REVIEW, 2010, 18 (04) : 213 - 217
  • [43] Sitagliptin - The first dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (09) : 434 - +
  • [44] Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes
    Scott, R.
    Wu, M.
    Sanchez, M.
    Stein, P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2007, 61 (01) : 171 - 180
  • [45] Dipeptidyl peptidase-4 inhibitor sitagliptin induces vasorelaxation via the activation of Kv channels and PKA
    Li, Hongliang
    Seo, Mi Seon
    An, Jin Ryeol
    Jung, Hee Seok
    Ha, Kwon-Soo
    Han, Eun-Taek
    Hong, Seok-Ho
    Bae, Young Min
    Na, Sung Hun
    Park, Won Sun
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2019, 384
  • [46] Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects
    Mistry, Goutam C.
    Bergman, Arthur J.
    Zheng, Wei
    Hreniuk, David
    Zinny, Miguel A.
    Gottesdiener, Keith M.
    Wagner, John A.
    Herman, Gary A.
    Ruddy, Marcella
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 66 (01) : 36 - 42
  • [47] Severe edema and blood blisters of the lower extremities caused by sitagliptin, a dipeptidyl peptidase-4 inhibitor
    Maita, Hiroki
    Kobayashi, Tadashi
    Akimoto, Takashi
    Osawa, Hiroshi
    Kato, Hiroyuki
    JOURNAL OF GENERAL AND FAMILY MEDICINE, 2022, 23 (02): : 124 - 125
  • [48] Renoprotective Effect of Sitagliptin (Dipeptidyl Peptidase-4 Inhibitor) aganist Cisplatin Induced Nephrotoxicity in Mice
    Shalaby, Amany
    Malek, Hala Abdel
    BRITISH JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 4 (09): : 1116 - 1129
  • [49] Discovery of DA-1229: A potent, long acting dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Kim, Heung Jae
    Kwak, Woo Young
    Min, Jong Pil
    Lee, Jae Young
    Yoon, Tae Hyun
    Kim, Ha Dong
    Shin, Chang Yell
    Kim, Mi Kyung
    Choi, Song Hyen
    Kim, Hae Sun
    Yang, Eun Kyoung
    Cheong, Ye Hwang
    Chae, Yu Na
    Park, Kyung Jin
    Jang, Ji Myun
    Choi, Soo Jung
    Son, Moon Ho
    Kim, Soon Hoe
    Yoo, Moohi
    Lee, Bong Jin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3809 - 3812
  • [50] ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase-4, for the treatment of Type 2 diabetes mellitus
    Jain, Mukul R.
    Joharapurkar, Amit A.
    Kshirsagar, Samadhan G.
    Patel, Vishal J.
    Bahekar, Rajesh H.
    Patel, Harilal V.
    Jadav, Pradip A.
    Patel, Pankaj R.
    Desai, Ranjit C.
    BRITISH JOURNAL OF PHARMACOLOGY, 2017, 174 (14) : 2346 - 2357
12345